Purchases and Sales Made in Q4 2024 in Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE) during Q4 2024. The information is specifically focused on institutions that hold shares of Aerovate Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.02K- 20.79% |
$2.02K - $2.83K
|
3.87K
$10.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1.8K- 86.73% |
$3.59K - $5.03K
|
276
$740
|
|
|
Jun 30, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-4.15K- 85.22% |
$8.26K - $11.6K
|
720
$1.93K
|
|
|
Feb 14, 2025
Q4 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-5.18K- 5.19% |
$10.3K - $14.5K
|
94.6K
$254K
|
|
|
May 29, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-9.15K- 40.24% |
$18.2K - $25.5K
|
13.6K
$36.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-26.5K- 58.42% |
$52.7K - $73.9K
|
18.9K
$50.5K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-29.9K- 11.47% |
$59.6K - $83.5K
|
231K
$619K
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-87K- 27.78% |
$173K - $243K
|
226K
$606K
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-131K- 66.59% |
$261K - $365K
|
65.7K
$176K
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-150K- 13.02% |
$298K - $418K
|
1M
$2.69M
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
SELL
|
- |
-217K- 93.05% |
$432K - $606K
|
16.2K
$43.5K
|
|
|
Feb 11, 2025
Q4 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-274K- 76.13% |
$544K - $763K
|
85.8K
$230K
|